Advertisement

Topics

Innovus Pharma Files Product License Application for the Commercialization of Its Seasonal Allergic Rhinitis Product in Canada

06:00 EDT 24 Aug 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
The Company looks to add AllerVarx™ to its growing portfolio of approved drugs and products in Canada Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the “Company”) (OTCQB Venture Market: INNV), an emergin...

Other Sources for this Article

Emerging Markets Consulting, LLC
James S. Painter III, 407 340 0226
jamespainter@emergingmarketsllc.com
or
Chesapeake Group
410-825-3930
info@chesapeakegp.com

NEXT ARTICLE

More From BioPortfolio on "Innovus Pharma Files Product License Application for the Commercialization of Its Seasonal Allergic Rhinitis Product in Canada"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Allergies
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...